Tissue engineering with a decellularized valve matrix
Tissue engineering requires scaffolds, which are of biologic or synthetic origin. Synthetic scaffolds have the advantage of sterility and no occurrence of immunologic barriers; however, the degradation process is unpredictable and thus the hemodynamic behavior is also unpredictable. Biologic scaffolds have the advantage that suitable animals, e.g., pigs, are abundant, the macroarchitecture is close to human anatomy which eases surgical handling and implantation, and their microarchitecture is adapted to load conditions. Disadvantages are the threats of rejection and infection, which also implies transmission of specific viruses. These drawbacks can be overcome only by complete decellularization.
KeywordsTissue Engineering Heart Valve Pulmonary Valve Pulmonary Regurgitation Tissue Engineer Heart Valve
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Sievers HH, Stierle U, Schmidtke C et al (2003) Decellularized pulmonary homograft (Synergraft) for reconstruction of the right ventricular outflow tract: first clinical experience. Z Kardiol 92:53–59CrossRefPubMedGoogle Scholar
Simon P, Kasimir MT, Seebacher G et al (2003) Early failure of the tissue engineered porcine heart valves SYNERGRAFTTM
in pediatric patients. Europ J Cardiothorac Surg 23:1002–1006CrossRefGoogle Scholar
Erdbrügger W, Konertz W, Dohmen P et al (2006) Decellularized xenogenic heart valves reveal remodeling and growth potential in vivo. Tissue Engineering 12:2059–2068CrossRefPubMedGoogle Scholar
Dohmen PM, Ozaki S, Yperman J et al (2003) Results of tissue engineered autoxenograft implanted in the juvenile sheep model. Med Sci Monit 9:BR97–BR107PubMedGoogle Scholar
Dohmen PM, da Costa F, Holinski S et al (2006) Is there a possibility for a glutaral-dehyde-free porcine heart valve to grow? Eur Surg Res 38:54–61CrossRefPubMedGoogle Scholar
Dohmen PM, Lembcke A, Hotz H et al (2002) Ross operation with the tissue engineered heart valve. Ann Thorac Surg 74:1438–1442CrossRefPubMedGoogle Scholar
Dohmen PM, Lembcke A, Holinski S et al (2007) Mid-term clinical results using a tissue engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg 84:729–736CrossRefPubMedGoogle Scholar
Kroll J, Buerbaum B, Beckmann A et al (2008) Kurzfristige Ergebnisse nach Pulmonalklappenersatz mit Matrix P plus Herzklappe. Clinical Research Cardiol 97:675Google Scholar
© Springer-Verlag Berlin Heidelberg 2010